Pharmaceutical combination comprising atorvastatin derivatives

Details for Australian Patent Application No. 2006313497 (hide)

Owner Ranbaxy Laboratories Limited

Inventors Bansal, Vinay S.; Sattigeri, Jitendra A.

Agent Callinan

Pub. Number AU-A-2006313497

PCT Pub. Number WO2007/054789

Priority 2964/DEL/2005 08.11.05 IN; 3033/DELl/2005 14.11.05 IN; 2967/DEL/2005 08.11.05 IN

Filing date 8 November 2006

Wipo publication date 18 May 2007

International Classifications

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

26 June 2008 PCT application entered the National Phase

  PCT publication WO2007/054789 Priority application(s): WO2007/054789

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006313498-Process for preparation of (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt

2006313493-Mu-conotoxin peptides and use thereof as a local anesthetic